Stem cell therapy has been demonstrated to induce profound healing activity in various forms of autoimmune disorders. Besides healing damaged tissues, stem cells have the unique ability to modulate the immune system so as to shut off pathological responses while preserving its ability to fight off disease.
Immunotherapy Car-T cells
Chimeric antigen receptors (CARs) are genetically engineered cells that are developed in the laboratory and infused into a patient to help in detecting and fighting cancer. The protein constructs stimulate anti-cancer T-cells, which in turn boost a patient’s immune system.
Chronic Obstructive Pulmonary Disease
COPD is mediated primarily by a pathogenic triad: inflammation, oxidative stress, and protease-antiprotease imbalance. The Objective of using Stem cells To provide the patient with a treatment that regenerate lung structure and induce lung functional recovery through reduction of inflammation, and induction of immunomodulation.
(NDs), such as Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease are characterized clinically by their subtle onset but chronic progression and involve the degeneration. In recent years, numerous studies have shown that stem cell transplantation elicits neurogenesis and angiogenesis by releasing neuroprotective factors brain- derived neurotrophic factor (BDNF) and nerve growth factor (NGF). Results have provided proof of principle that cell replacement can work in humans with these types of conditions.
The use of cell-based therapies has been shown to produce a profound healing activity in several forms of arthritis. While repairing damaged tissues, they have the unique ability to modify the immune system to suppress pathological responses, while preserving the ability to fight disease. By administering adult mesenchymal stem cells, we have observed improvements in many patients with osteoarthritis treated at our center.
Spinal Cord Injury
A number of publications and case studies support the feasibility of treating spinal cord injury with allogeneic human umbilical cord tissue-derived stem cells and autologous bone marrow-derived stem cells.Through administration of highly concentrated culture and expanded mesenchymal stem cells, we have observed improvements in spinal cord injury patients treated at our facilities.
Localized injections and IV infusions treatments using mesenchymal stem cells are used to improve the aesthetic appearance, and overall health these cells are responsible for the production of collagen, elastin and hyaluronic acid. The treatments using stem cells presented a better response with more lasting differences from other products.
Stem cell therapies are a viable treatment option for treating or aiding recovery from many conditions and common sports injuries. These treatments have reduced the need for prescription medication and surgery and are proving to be a helpful tool for athletes trying to manage or eliminate pain.
The benefits of utilizing cell therapy to improve sexual dysfunction includes For women, it helps treat and improve anorgasmia, dyspareunia, vaginal dryness, and urinary incontinence. For men, it helps improve overall vascular function, nerve sensitivity in the penis and erectile dysfunction. The use of growth factors, anti-inflammatory cytokines, and mesenchymal stem cells has shown significant improvement to our patients.
The rationale behind treating autism with Mesenchymal stem cells is that autism, and its degree of severity, has been significantly correlated inflammatory and neuro-inflammatory cytokines including macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). Intravenous administration of umbilical cord MSCs has been shown in multiple clinical trials to decrease inflammation. Decreasing inflammation in the autistic patient may alleviate symptoms of autism.
This condition is caused by an immune mediated attack targeting components of the myelin sheath. The myelin sheath is known to act as an “insulator” for neurons so that they can communicate properly with each other.Mesenchymal stem cells (MSCs), have immune regulatory properties which may stop the immune system from attacking the myelin sheath.Current approaches, such as interferon, copaxone, or immuno-suppressants all act in a nonspecific manner blocking immune responses against the myelin sheath. While these approaches are useful for reducing the severity of disease, they do not repair the damage to nervous system tissue that has already.